Biochemotherapy with low doses of subcutaneous interleukin-2 in patients with melanoma: results of a phase II trial

María González Cao, Susana Puig, Josep Malvehy, Josep Eugeni Herrero, Rosa María Martí, Carlos Conill, Marcelo Sánchez, Begoña Mellado, Pere Gascón, Teresa Castel
  • Clinical & Translational Oncology, July 2005, Springer Science + Business Media
  • DOI: 10.1007/bf02710171

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1007/bf02710171

The following have contributed to this page: Susana Puig

In partnership with: